¡Ya estamos en ! Descubre más

SCTL

Societal CDMO, Inc. Common Stock

SCTL

Capitalización de mercado USD 116 M

Excluida de cotización

SCTL dejó de cotizar en bolsa el 5 de abril de 2024.

Volver al ranking

Acerca de: Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. They have an expertise in solving complex manufacturing problems, the Company provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

Empleados: 258

Salud Fabricantes de medicamentos - General

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 0%

Neutral 0%

Negativo 0%

SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Societal CDMO, Inc. (NasdaqCM: SCTL) to CoreRx, Inc. Under the terms of the proposed transaction, shareholders of Societal will receive $1.10 in cash for each share of Societal that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.

SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL

SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Societal CDMO, Inc. (NasdaqCM: SCTL) to CoreRx, Inc. Under the terms of the proposed transaction, shareholders of Societal will receive $1.10 in cash for each share of Societal that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.

SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL

Why Is Societal CDMO (SCTL) Stock Up 133% Today?

Societal CDMO (NASDAQ: SCTL ) stock is rocketing higher on Thursday after the pharmaceutical development and manufacturing company announced an acquisition agreement with CoreRx. This agreement will have CoreRx acquiring Societal CDMO with a tender offer for SCTL shares.

Why Is Societal CDMO (SCTL) Stock Up 133% Today?

SCTL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Societal CDMO, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Societal CDMO, Inc. (NASDAQ: SCTL) to CoreRx, Inc. for $1.10 per share in cash is fair to Societal CDMO shareholders. Halper Sadeh encourages Societal CDMO shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Societ.

SCTL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Societal CDMO, Inc. Is Fair to Shareholders

Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.

Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging

Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers

Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers

Societal CDMO Reports Inducement Grants for New Staff

SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization.

Societal CDMO Reports Inducement Grants for New Staff

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™